Pulsecare Medical announced today that Chinese regulatory authorities granted marketing approval for its pulsed field ablation technology. Shenzhen, China-based Pulsecare develops the NxPFA nanosecond PFA system. It utilizes high-voltage nanosecond pulses for pulmonary vein isolation (PVI) in AFib treatment. The company says its technology marks … [Read more...] about Pulsecare gets regulatory nod for nanosecond PFA in China
